We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
161 hedge funds and large institutions have $731M invested in Revance Therapeutics, Inc. in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 61 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 16
3% more funds holding
Funds holding: 156 → 161 (+5)
10% more call options, than puts
Call options by funds: $14.1M | Put options by funds: $12.8M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 61
28% less capital invested
Capital invested by funds: $1.02B → $731M (-$284M)
Holders
161
Holders Change
+5
Holders Change %
+3.21%
% of All Funds
2.71%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
48
Reduced
61
Closed
16
Calls
$14.1M
Puts
$12.8M
Net Calls
+$1.27M
Net Calls Change
-$16.3M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$19.1M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$10.2M |
| 3 |
PA
Perceptive Advisors
New York
|
+$6.7M |
| 4 |
BlackRock
New York
|
+$6.12M |
| 5 |
Millennium Management
New York
|
+$5.18M |
